Hua F - Search Results

1

Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial.

Song Z, Li Y, Chen S, Ying S, Xu S, Huang J, Wu D, Lv D, Bei T, Liu S, Huang X, Xie C, Wu X, Fu J, Hua F, Wang W, Xu C, Gao C, Cai S, Lu S, Zhang Y. Song Z, et al. Among authors: hua f. BMC Med. 2022 Feb 1;20(1):42. doi: 10.1186/s12916-022-02245-z. BMC Med. 2022. PMID: 35101045 Free PMC article. Clinical Trial.

2

Pyrotinib in Patients with HER2-Amplified Advanced Non-Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Trial.

Song Z, Lv D, Chen SQ, Huang J, Li Y, Ying S, Wu X, Hua F, Wang W, Xu C, Bei T, Gao C, Sun Z, Zhang Y, Lu S. Song Z, et al. Among authors: hua f. Clin Cancer Res. 2022 Feb 1;28(3):461-467. doi: 10.1158/1078-0432.CCR-21-2936. Epub 2021 Nov 9. Clin Cancer Res. 2022. PMID: 34753778 Clinical Trial.

3

Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy.

Cui EH, Li HJ, Hua F, Wang B, Mao W, Feng XR, Li JY, Wang X. Cui EH, et al. Among authors: hua f. Acta Pharmacol Sin. 2013 Feb;34(2):309-13. doi: 10.1038/aps.2012.125. Epub 2012 Sep 17. Acta Pharmacol Sin. 2013. PMID: 22983388 Free PMC article.

4

RAGE genetic polymorphisms are associated with risk, chemotherapy response and prognosis in patients with advanced NSCLC.

Wang X, Cui E, Zeng H, Hua F, Wang B, Mao W, Feng X. Wang X, et al. Among authors: hua f. PLoS One. 2012;7(10):e43734. doi: 10.1371/journal.pone.0043734. Epub 2012 Oct 5. PLoS One. 2012. PMID: 23071492 Free PMC article.

5

Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.

Shi X, Liu Z, Liu Z, Feng X, Hua F, Hu X, Wang B, Lu K, Nie F. Shi X, et al. Among authors: hua f. EBioMedicine. 2018 Nov;37:177-187. doi: 10.1016/j.ebiom.2018.10.004. Epub 2018 Oct 9. EBioMedicine. 2018. PMID: 30314898 Free PMC article.

6

[A meta-analysis of the timing of chest radiotherapy in patients with limited-stage small cell lung cancer].

Zhao H, Gu J, Hua F, Xu H, Li L, Yang B, Han Y, Liu S, Hong S. Zhao H, et al. Among authors: hua f. Zhongguo Fei Ai Za Zhi. 2010 Sep;13(9):892-7. doi: 10.3779/j.issn.1009-3419.2010.09.10. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20840819 Free PMC article. Chinese.

7

Association between P(16INK4a) promoter methylation and non-small cell lung cancer: a meta-analysis.

Gu J, Wen Y, Zhu S, Hua F, Zhao H, Xu H, You J, Sun L, Wang W, Chen J, Zhou Q. Gu J, et al. Among authors: hua f. PLoS One. 2013;8(4):e60107. doi: 10.1371/journal.pone.0060107. Epub 2013 Apr 5. PLoS One. 2013. PMID: 23577085 Free PMC article.

8

The role of adiponectin (ADIPOQ) gene polymorphisms in the susceptibility and prognosis of non-small cell lung cancer.

Cui E, Deng A, Wang X, Wang B, Mao W, Feng X, Hua F. Cui E, et al. Among authors: hua f. Biochem Cell Biol. 2011 Jun;89(3):308-13. doi: 10.1139/o11-005. Epub 2011 May 27. Biochem Cell Biol. 2011. PMID: 21619462

9

A meta-analysis of the relationship between RARβ gene promoter methylation and non-small cell lung cancer.

Hua F, Fang N, Li X, Zhu S, Zhang W, Gu J. Hua F, et al. PLoS One. 2014 May 5;9(5):e96163. doi: 10.1371/journal.pone.0096163. eCollection 2014. PLoS One. 2014. PMID: 24796328 Free PMC article. Review.

10

HapMap-based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers.

Hua F, Guo Y, Sun Q, Yang L, Gao F. Hua F, et al. Thorac Cancer. 2019 Apr;10(4):601-606. doi: 10.1111/1759-7714.12954. Epub 2019 Feb 26. Thorac Cancer. 2019. PMID: 30807688 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

881 results

Search Page

Filters